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ABSTRACT 
The concept of mixed matrix membrane (MMM) chromatography is an alternative that 
provides a simple method for the preparation of adsorptive membranes, yet results in high 
quality membrane chromatography performance. MMMs are prepared by incorporating an 
ion exchange resin (or any adsorptive resin) into a membrane polymer solution prior to 
membrane casting. In this study, MMM will be prepared by combining cation and anion 
simultaneously in EVAL based polymer solution. The membrane will be used for whey 
protein fractionation to recover both acidic and basic protein. Whey is the liquid byproduct 
of casein precipitation of milk in the cheese or casein manufacturing industries and of milk 
concentration prior to milk powder production (Saufi, 2010).  
 
Rather than using the high cost ion exchange resin that purposely design for protein 
fractionation, this study will using a low cost ion exchanger resin that commonly used at the 
industry. The 7.5 wt% anion resin (MP500) will be bland with 7.5 wt% cation resin 
(CNP105) in the 15wt% EVAL based polymer solution. This mixed mode interaction 
MMM will applied for whey protein fractionation. The feasibility of MMM was tested in 
whey protein fractionation processes. WPI solutions were diluted to 2mg/mL with different 
pH binding buffer solution (pH 4, 5, 6, 7, and 8). The whey protein compositions after 
binding were assayed using UPLC column ACQUITY UPLC PrST using a C4 Jupiter 
column. A combination of pH and salt elution using different pH elution buffers will be 
performed to selectively elute the bound protein on the membrane. This membrane had a 
maximum static binding capacity of 0.260 mg/mL β-Lac, 0.214 mg/mL BSA, and 0.118 
mg/mL α-Lac per membrane at pH 5. The membrane was successfully applied to bind 
acidic and basic proteins simultaneously from a mixture. Based on batch elution 
experimental results, a productivity of 0.156 mg whey protein mL
-1
 membrane h
-1
 was 
calculated using this customized mixed mode MMM. 
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ABSTRAK 
Konsep campuran matriks membran (MMM) kromatografi adalah alternatif yang 
menyediakan kaedah yang mudah bagi penyediaan membran serapan, namun mampu 
memberi prestasi yang berkualiti tinggi kromatografi membran. MMMs disediakan dengan 
menggabungkan pertukaran resin ion (atau mana-mana resin serapan) ke dalam larutan 
polimer membran sebelum membran dihasilkan.Dalam kajian ini, MMM akan disediakan 
dengan menggabungkan kation dan anion pada masa yang sama dalam larutan polimer 
berasaskan EVAL. Membran akan digunakan untuk protein whey fraksinasi untuk 
mendapatkan kedua-dua protein berasid dan asas. Whey adalah hasil sampingan cecair 
kasein dalam susu dalam industri pembuatan keju atau kasein dan konsentrasi susu sebelum 
pengeluaran susu serbuk (Saufi, 2010).  
Daripada menggunakan kos ion pertukaran resin yang tinggi yang sengaja mereka bentuk 
untuk protein fraksinasi, kajian ini akan menggunakan ion kos penukar resin rendah yang 
biasa digunakan di industri. 7.5% berat anion resin (MP500) akan dicampur dengan 7.5% 
berat kation resin (CNP105) dalam larutan polimer berasaskan 15 wt% EVAL. Mod 
campuran interaksi MMM ini akan digunakan untuk protein whey fraksinai. Kesesusaian 
MMM akan diuji dalam proses whey proteinfraksinai. Larutan WPI akan dicairkan kepada 
2mg/mL dengan menggunakan larutan berbeza mengikut pH (pH 4, 5, 6, 7, dan 8). 
Komposisi protein whey selepas proses ikatan telah dicerakin menggunakan kolum UPLC 
ACQUITY UPLC PrST yang menggunakan C4 Jupiter. Gabungan pH dan garam digunakan 
dengan larutan pH yang berbeza untuk menceraikan protein yang terikat pada 
membran.Membran ini mempunyai kapasiti mengikat statik maksimum 0,260 mg / mL β-
Lac, 0.214 mg / mL BSA, dan 0.118 mg / mL α-Lac setiap membran pada pH 5. Membran 
telah berjaya digunakan untuk mengikat protein berasid dan asas pada masa yang sama dari 
campuran. Berdasarkan keputusan eksperimen kelompok elution, produktiviti sebanyak 
0.156 mg whey protein mL-1 membran h-1 yang dikira menggunakan mod campuran ini 
disesuaikan MMM. 
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1 INTRODUCTION 
1.1 Background 
An operation to recover and purify protein products from various biological feed streams is 
called protein bio-separation. In the pharmaceutical, biotechnological and food industry it is 
an important unit operation. The cost of protein purification is the main concerns in the 
production of bio-product as it contributes major cost which is about 50%-90% of total cost 
production. A bioreactor product mostly contains a lot of impurities that need to be 
removing to get the final desired bio-product. 
 
The physical and/or chemical properties of the individual protein must be utilized to be able 
to isolate a specific protein from a crude mixture. There is no single or simple way to purify 
all kinds of proteins. Procedures and conditions used in the purification process of one 
protein may impact in the inactivation of another. When choosing purification method, the 
final goal also has to be considered. The purity required depends on the purpose for which 
the protein is required. 
 
In the early days of protein chemistry, the only practical way to separate different types of 
proteins was by taking advantage of their relative solubility. Part of a mixture was caused to 
precipitate through alteration of some properties of the solvent e.g. addition of salts, organic 
solvents or polymers, or varying the pH or temperature. Fractional precipitation is still 
frequently used for separation of gross impurities, membrane proteins and nucleic acids. 
Under certain conditions, proteins adsorb to a variety of solid phases, preferably in a 
selective manner. Calcium phosphate gels have frequently been used to specifically adsorb 
proteins from heterogeneous mixtures. The adsorption principle is further explored in 
column chromatography. Due to their high resolving power, different chromatography 
techniques have become dominant for protein purification. 
 
Biological molecules can be separated from one another by exploiting differences in their 
size, charge, or affinity for a particular ligand or solid support. Chromatography is the 
laboratory technique that allows separation of molecules based on their differential 
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migration through a porous medium. Although there are many different types of 
chromatography, the principle behind the separation of the molecules is the same: a mixture 
of compounds will have different affinities for the stationary phase (solid support or matrix) 
on which it is adsorbed and the mobile phase (buffer or solvent) passing through the 
stationary phase. 
 
Recently, most chromatography systems use packed bed columns to contain the stationary 
phase or matrix. However few limitations have been identified within this system. The 
limitations of packed bed column chromatography, such as high pressure drop, long 
processing times due to slow intraparticle diffusion and complicated scale up procedures 
(Ghosh 2002; Kawai et al. 2003; Klein 2000; Van Reis and Zydney 2001; Zou et al. 2001), 
have encouraged the search for new kinds of column material and configuration. 
 
Membrane chromatography, which uses adsorptive membranes, is one of the alternatives 
that can overcome some of the limitations of packed bed column chromatography. 
Adsorptive membranes which have a specific functionality or ligand will bind to the target 
protein with different adsorption mechanisms depending on the type of ligand. Membrane 
chromatography systems have shown great advantages such as (Ghosh 2002; Kawai et al. 
2003; Wickramasinghe et al. 2006; Zou et al. 2001): 
 
a) Low pressure drop across the column 
b) Convective mass transfer properties of solutes to the binding sites 
c) High flow rate operation with maintain performance 
d) Easy column packing with low column clogging tendency 
e) Uncomplicated scale up procedures 
f) Low cost and the ability to be used as a single disposable device, especially for 
pharmaceutical or food applications which require very stringent cleaning protocols 
 
Normally, preparation of adsorptive membranes involves complex and harsh chemical 
modifications. The concept of mixed matrix membrane (MMM) chromatography, 
developed by Wessling’s group (Avramescu et al. 2003), is an alternative that provides a 
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simple method for the preparation of adsorptive membranes, yet, results in a high quality 
membrane chromatography performance. Mixed matrix membranes (MMMs) only need the 
physical incorporation of an ion exchange resin (or any adsorptive resin) into the membrane 
polymer solution prior to membrane casting. The chemical modifications necessary for 
incorporating adsorptive ligands are thus decoupled from the membrane preparation step. 
The availability of various low cost resins suitable for protein adsorption can make this 
technique cost effective. 
 
In previous study, Saufi and Fee (2011) had prepared a single matrix that incorporated 
simultaneous cation and anion exchange functionalities. A mixed mode MMM (M5) was 
synthesized by incorporating SP Sepharose cation resin and Lewatit MP500 anion resin into 
an EVAL base polymer solution at a ratio based on the relative levels of acidic and basic 
proteins present in whey. However, the SP Sepharose cation resin used is costly. In the 
current study, an alternative cation resin which is Lewatit CNP105 was used for whey 
protein fractionation. The MMM was bind to whey protein solution at different pH and 
eluted with different elution solution.  
 
1.2 Objectives 
The main objective of this research is to produce, characterize and performance evaluation 
of mixed mode interaction MMM chromatography of Lewatit MP500 anion exchanger resin 
and Lewatit CNP105 cation exchanger resin for whey protein fractionation. 
1) Anion exchange MMM chromatography is developed by incorporating a several 
potential anion exchanger resins, Lewatit MP500 into ethylene vinyl alcohol 
(EVAL) base membrane. The anionic MMM is expected to bind acidic whey 
proteins such as β-Lactoglobulin, α-Lactalbumin, Bovine serum albumin and 
Immunoglobulins. 
 
2) A cation exchange MMM is developed using CNP105 resin to recover lactoferrin 
and lactoperoxidase from whey protein. The performance of the membrane is 
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evaluated and the feasibility of using batch fractionation in the separation process is 
studied.  
 
3) Using the MMM concept, we are able to capture the positively and negatively whey 
proteins in one run. However, further elution strategy study is needed to elute the 
protein of interest that bound on mixed mode interaction MMM. Elution protocol of 
a combination of pH change and salt elution is also investigated to explore the 
possibility of eluting bound proteins individually from 1.5mL whey protein injected 
into the M5 (Mixed Mode Mixed Matrix Membrane). 
 
1.3  Scope of research 
In order to fulfill the research objective, the following scopes has been outlined.  
i) To study the whey protein binding to mixed mode interaction MMM at different 
pH from pH 4 to pH 8.  
ii) To prepare and determine the static binding capacity of mixed mode interaction 
MMM.  
iii) To perform the elution study using different elution buffers in fractionation of 
whey protein component using mixed mode interaction MMM chromatography. 
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2 LITERATURE REVIEW 
2.1 Whey protein 
 
Whey is a liquid by-product of casein precipitation of milk in the cheese or casein 
manufacture in the dairy industry and of milk concentration prior to milk powder 
production. After the casein curd separates from the milk, following coagulation of the 
casein proteins through the action of chymosin (rennet) or mineral/organic acid, the 
remaining watery and thin liquid is called whey (Zadow, 1994) as shown in Figure 2.1. Its 
colour depends on the quality and type of milk used. It has a yellow/green colour, or 
sometimes even a bluish tinge. Whey can be made from any type of milk mostly ruminant’s 
milk, with cow’s milk being the most popular in western countries, while in some regions of 
the world, goat’s, sheep’s, and even camel’s milk can be used in the manufacture of dairy 
products that result in the generation of whey. Whey protein comprises ~50% β-
Lactoglobulin, ~20% α-Lactalbumin, ~15% glycomacropeptide (in renneted whey only), 
and ~15% minor protein/peptide components (e.g., immunoglobulins, lactoferrin, 
lactoperoxidase, serum albumin, lysozyme, and growth factors). 
 
Table 2.1: Comparison of the proximate analysis of bovine milk and whey (Zadow, 1994; 
Smithers et al., 1996). 
Component Content (%, w/v) 
Milk Whey 
Casein protein 2.8 < 0.1 
Whey protein 0.7 0.7 
Fat 3.7 0.1 
Ash 0.7 0.5 
Lactose 4.9 4.9 
Total solids 12.8 6.3 
 
 
Whey once considered a waste product. The disposal of whey causes severe environmental 
pollution problems as it having a biological oxygen demand (BOD) value of about 35- 60 g 
L
−1
 and a chemical oxygen demand (COD) value of 80-100 g L
−1
 as sewage (Bhattacharjee 
et al., 2006). Thus in most countries, the government and other regulatory authorities have 
restricted or banned the disposal of untreated whey (Smithers 2008). This legislative 
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restriction on whey disposal encouraged a deeper exploration of whey protein-based 
ingredients. Finally, whey has become a new source of functional ingredients when stricter 
environmental laws were approved and more attention was given to its benefits (Marshall, 
K., 2004). Now, whey is generally considered as a functional food, which has measurable 
effects on health outcomes, and the bioactive properties of whey proteins and whey protein 
fractions are becoming increasingly recognized (Kruger et al., 2005; Marshall, 2004; 
Michaelidou & Steijns, 2006; Toba et al., 2000). Enormous quantities of whey are produced 
annually worldwide. At 130 million tons is estimated for the world production of cheese 
whey per year, accounting for around 780,000 tons of protein (Monteiro et al., 2008). 
 
Whey proteins consist to about 18–20% of the total milk proteins and its major components 
are β-Lactoglobulin, α-Lactalbumin, bovine serum albumin and immunoglobulin, 
representing, 50%, 20%, 10% and 10% of the whey fraction, respectively (Jovanovic et al., 
2007). Whey proteins also consist of numerous minor proteins, such as lactoferrin, 
lactoperoxidase, proteose peptone, osteopontin, and lizozyme (Hahn et al., 1998). The 
detailed whey protein profile, including general chemical and physiochemical properties, is 
depicted in Table 2.2. Relying on the quality of the milk, 10 kg of milk will produce only 1-
2 kg of cheese, whereas the rest of it will emerge as liquid whey (Bhattacharjee et al., 2006). 
Figure 2-2 shows the main components of bovine milk, where whey protein only represents 
about 20% of the total protein in milk. 
 
Figure 2.1: Schematic diagram of acid- and rennet-mediated cheese making. 
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Table 2.2: Protein profiles of whey and primary structure basic properties (de Wit, 1998; 
Eigel et al., 1984; Brew et al., 1970; Korhonen, 1995; Andersson and Mattiasson, 2006). 
Protein Concentration 
(g/l) 
Molecular 
weight 
(Da) 
Number of 
amino acids 
residues 
Isoelectric point 
(pI) 
β-Lactoglobulin 1.3 18, 277 162 5.2 
α-Lactalbumin 1.2 14, 175 123 4.5-4.8 
Bovine serum 
albumin 
0.4 66, 267 582 4.7-4.9 
Immunoglobulins 
(A, M and C) 
0.7 25,000 (light 
chain) + 50, 
000-70,000 
(heavy chain) 
- 5.5-8.3 
Lactoferrin 0.1 80, 000 700 8-9.5 
Lactoperoxidase 0.03 70, 000 612 9.5 
Glycomacropetide 1.2 6700 64 - 
 
 
Figure 2.2: Main components of bovine milk and composition of bovine protein (Splitt et 
al. 1996). 
 
Normally, whey protein products are available in three major forms: concentrates (WPC), 
isolates (WPI) and hydrolysates (WPH) (Huffman and Harper, 1999). Whey proteins can be 
converted into whey protein concentrate (WPC) (35-80% protein) or whey protein isolate 
(WPI) (80-95% protein) for bulk use (Brans et al., 2004). WPC is a mixture of all whey 
proteins obtained by membrane concentration of whey, retaining significant amounts of the 
minerals, lipids, and lactose from whey, WPI is a higher quality and higher value mixture of 
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the whey proteins, manufactured using either membrane filtration or ion-exchange 
adsorption (Turhan and Etzel, 2004). Particularly due to its high protein content WPI is 
usually included in sports formulas, infant formulas or medical formulas. WPI also can be 
used as a source of pure proteins or can be hydrolysed to obtain valuable peptides (Lucena 
et al., 2007).  
 
In the past two decades in order to earning a significant income from individual proteins 
from whey, the dairy industry globally has moved from being based solely on commodity 
food production (Fee and Chand 2006; Horton 1995; Huffman and Harper 1999). The added 
value of whey has increased dramatically over the past 50 years as illustrated in Figure 2.3, 
along with the advances in science and technology (adapted from Smithers 2008). Whey 
components, mainly proteins and peptides, will increasingly be preferred as ingredients for 
functional foods and nutraceuticals and as active medicinal agents (Smithers 2008). 
 
Figure 2.3: Schematic representation of the relative increase in value of whey 
protein/peptide products with increasing underpinning scientific knowledge of whey solids 
and advances in technology and marketplace sophistication over the past approximately 50 
years (adapted from Smithers 2008). 
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Each whey protein has unique properties for nutritional, therapeutic, biological and food 
ingredient applications (Marshall, 2004). Nevertheless, these unique properties are largely 
unrealized and the acceptance of these products by the food processing industry has limited 
due to the lack of consistency in the gross composition and functionality, interactions 
between components, and degradation during processing. Moreover, the presence of lipid 
and protein impurities can caused WPCs develop a stale off-flavor (Zydney, 1998). Thus, 
there is a challenge in whey protein fractionation to produce individual whey proteins with 
well characterized functional and biological properties by a process which will not denature 
but retain its nutritional and other properties (Bhattacharjee et al., 2006). 
 
2.1.1  Applications and biological activities of whey protein 
components 
The main applications and biological activities of individual major whey proteins are 
summarized in Table 2.3. 
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Table 2.3: Main applications and biological activities of individual major whey proteins. 
Protein Biological function Refrerences 
Whole whey proteins i. Prevention of cancer; 
 Breast and intestinal cancer 
 Chemically induced cancer 
ii. Increment of gluthatione levels; 
 Increase of tumour cell vulnerability 
 Treatment of HIV patients 
iii. Antimicrobial activities  
iv. Increment of satiety response 
 Increment in plasma amino acids, 
cholecystokinin and glucagon-like peptide 
v. β-Lac free whey would also serve as the primary 
protein constituent of hypoallergenic infant 
formulas.  
Gill and Cross (2000) 
Badger et al. (2001)  
MacIntosh et al. (1995) 
Hakkak et al. (2000)  
Rowlands et al. (2001) 
Parodi (1998) 
Micke et al. (2001) 
Micke et al. (2002) 
Clare et al. (2003) 
Hall et al. (2003) 
Casal et al. (2006) 
β-Lactoglobulin i. Transporter 
 Retinol 
 Palmitate 
 Fatty acids 
 Vitamin D   
 Cholesterol  
ii. Enhancement of pregrastic esterase activity  
Puyol et al. (1991) 
Wu et al. (1999) 
Puyol et al. (1991) 
Wang et al. (1997) 
Perez et al. (1992) 
Warme et al. (1974) 
Farrell et al. (1987) 
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iii. Transfer of passive immunity to the newborn  
iv. Regulation of mammary gland phosphorus 
metabolism  
v. Binding and transport of retinol, vitamin D and 
palmitic acid 
vi. Enzymic synthesis of prostaglandins 
vii. Olfactation, opiodergic, cryptic coloration 
viii. Anti-hypertensive, anti-cancer, 
hypocholesterolemic 
ix. Due to its good solubility, β-Lac has a potential 
use in power drinks and is a good source of 
essential amino acids  
x. Suitable for confection production due to its 
good gelling formation and better foam 
stabilizer.  
Flower, D.R.  (1996) 
Horton (1995) 
Cowan and Ritchie (2007) 
Zydney (1998) 
Maduira et al. (2007) 
α- Lactalbumin i. Due to its high tryptophan content, high 
digestibility, and lower potential for causing 
allergies, α-Lac is the preferred protein source 
for infant formulas, when compared to β-Lac.  
ii. Applicable as a nutraceutical owing to its high 
content in tryptophan. 
iii. Possesses therapeutic uses due to its high 
Gurgel et al. (2000) 
Zydney (1998) 
(Konrad and Kleinschmidt (2008) 
de Wit (1998) 
Markus et al. (2002) 
Ganjam et al. (1997) 
Greene, L.H. et al. (1999) 
12 
 
cytotoxicity. 
iv. Contraceptive agent because it has strong affinity 
for glycosylated receptors on the surface of 
oocytes and spermatozoids. 
v. Prevention of cancer  
vi. Lactose synthesis  
vii. Treatment of chronic stress-induced disease  
viii. Binding of calcium, absorption 
ix. Lactose synthesis 
x. Tumor cells apoptosis 
Maduira et al (2007) 
Bovine serum albumin i. Fatty acid binding  
ii. Anti-mutagenic function  
iii. Prevention of cancer  
iv. Immunomodulation 
 Disease protection through passive immunity 
v. Transport, metabolism and distribution of ligands 
vi. Protection from free radicals 
vii. Contribution to osmotic pressure of blood 
viii. Widely used in food and therapeutic applications  
ix. Has a good gelling property  
x. Nutrient in cell and microbial culture 
xi. In restriction digests, BSA is used to stabilize 
Maduira et al (2007) 
Walzem, Dillard, and German 
(2002) 
Bosselaers, I.M. et al.(1994) 
Laursen et al. (1990) 
Ormrod and Miller (1991) 
Mitra et al. (1995), Tomita et al. 
(1995), 
Loimaranta et al. (1999) 
Farrel, H.M. et al. (2004) 
Zydney (1998)  
Matsudomi et al. (1991) 
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some enzymes during digestion of DNA and to 
prevent adhesion of the enzyme to reaction tubes 
and other vessels. 
xii. Used to determine the quantity of other proteins, 
by comparing an unknown quantity of protein to 
known amounts of BSA. 
Geselowitz and Neckers, (1995). 
 
Immunoglobulins i. Antibacterial activity 
 HIV 
ii. Antifungal activity  
iii. Opioid activity  
iv. Immunological protection against microbial 
pathogens and toxins 
v. Protect mammary gland against infection 
vi. Antigen binding 
vii. Capable of preventing the adhesion of microbes 
to surfaces  
viii. Inhibiting bacterial metabolism by blocking 
enzymes Agglutinating bacteria and neutralizing 
toxins and viruses  
Oona et al. (1997) 
 Freedman et al. (1998) 
Okhuysen et al. (1998) 
Sharpe et al. (1994) 
 El-Loly (2007) 
Lactoferrin i. Broad spectrum antimicrobial activity 
ii. Promotion of iron transfer and absorption  
iii. Cancer prevention  
Adlerova et al. (2008)  
Horton (1995) 
Lu et al. (2007)  
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iv. Cell proliferation and differentiation  
v. Antiviral, antibacterial and antiparasitic activity  
vi. Oral administration of LF exerts beneficial 
effects on the health of humans and animal;  
 Anti-infective  
 Anticancer  
 Anti-inflammatory effects  
vii. Commercially used as a; 
 Natural bioactive ingredient in supplement foods 
(e.g. infant formulae and dietary supplement 
tablets)  
 Skin care  
 Oral health care products  
Tomita et al. (2009)  
Wakabayashi et al. (2006) 
Wakabayashi et al. (2006) 
Yamauchi et al. (2006) 
Lactoperoxidase i. Catalyzes the oxidation of thiocynate by 
hydrogen peroxide.  
ii. Generates intermediate products with 
antibacterial properties which kill or inhibit the 
growth of wide range of bacteria, viruses, fungi, 
molds and protozoa.  
iii. Preserve raw milk quality during transportation 
from the farmer to the dairy plant when not 
possible to used mechanical refrigeration. 
Korhonen (2009)  
Seifu et al. (2005)  
Shakeel ur et al. (2002) 
Seifu et al. (2005) 
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2.2 Technologies for whey protein fractionation 
2.2.1 Column based chromatography 
 
In downstream processing of protein mixture, chromatography is a very well known unit 
operation. In chromatographic techniques, the different migration of the component of 
interest between the stationary phase (i.e. matrix phase) and continuous phase (i.e. solvent) 
in the system is the cause of the principle separation occurred. Depending on the process 
scale, chromatography media (i.e. stationary phase) is normally packed into a column from 
several centimeters to several meters diameter. Various types of chromatography mode or 
interaction are available, such as size exclusion, ion exchange, hydrophobic interaction and 
reverse phase chromatography. They differ in terms of the separation mechanism and 
selection of stationary and continuous phase. Table 2.4 gives a brief performance 
comparison between several types of chromatographic interaction that are normally used in 
column chromatography (Chaga, 2001; Suen et al., 2003). The advantages and 
disadvantages between different formats of stationary phase in chromatographic system are 
given in Table 2.5 (Ghosh, 2003). 
 
Previous studies on whey fractionation using column chromatography are summarized in 
Table 2.6. Most of them appeared in the literature for the past 10 years.  
